Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.

Whitfield JB, Masson S, Liangpunsakul S, Hyman J, Mueller S, Aithal G, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Daly AK, Cordell HJ, Liang T, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Bence C, Jacquet JM, Louvet A, Moirand R, Nahon P, Naveau S, Perney P, Podevin P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TM, Seth D; GenomALC Consortium.

Alcohol. 2018 Feb;66:1-7. doi: 10.1016/j.alcohol.2017.07.006. Epub 2017 Sep 23.

2.

Effect of alcohol consumption on liver stiffness measured by transient elastography.

Bardou-Jacquet E, Legros L, Soro D, Latournerie M, Guillygomarc'h A, Le Lan C, Brissot P, Guyader D, Moirand R.

World J Gastroenterol. 2013 Jan 28;19(4):516-22. doi: 10.3748/wjg.v19.i4.516.

3.

The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.

Gough G, Heathers L, Puckett D, Westerhold C, Ren X, Yu Z, Crabb DW, Liangpunsakul S.

Alcohol Clin Exp Res. 2015 Aug;39(8):1493-500. doi: 10.1111/acer.12780. Epub 2015 Jun 25.

4.

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.

Wang J, Li P, Jiang Z, Yang Q, Mi Y, Liu Y, Shi R, Zhou Y, Wang J, Lu W, Li S, Liu D.

Korean J Intern Med. 2016 May;31(3):479-87. doi: 10.3904/kjim.2015.253. Epub 2016 Mar 30.

5.

Survey of alcohol-related cirrhosis at a tertiary care center in North East India.

Bhattacharyya M, Barman NN, Goswami B.

Indian J Gastroenterol. 2016 May;35(3):167-72. doi: 10.1007/s12664-016-0651-2. Epub 2016 May 5.

PMID:
27146041
6.

[Plasma levels of folate and vitamin B(12) in patients with chronic liver disease].

Muro N, Bujanda L, Sarasqueta C, Gil I, Hijona E, Cosme A, Arenas J Jr, Elosegui ME, Sarasola M, Calpasoro J, Arenas JI.

Gastroenterol Hepatol. 2010 Apr;33(4):280-7. doi: 10.1016/j.gastrohep.2009.12.001. Epub 2010 Mar 4. Spanish.

PMID:
20206409
7.

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.

Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.

Hepatology. 1996 Dec;24(6):1399-403.

PMID:
8938169
8.

Assessing alcohol intake & its dose-dependent effects on liver enzymes by 24-h recall and questionnaire using NHANES 2001-2010 data.

Agarwal S, Fulgoni VL 3rd, Lieberman HR.

Nutr J. 2016 Jun 22;15(1):62. doi: 10.1186/s12937-016-0180-y.

9.

Risk factors for alcohol hepatotoxicity among male alcoholics.

Yates WR, Petty F, Brown K.

Drug Alcohol Depend. 1987 Nov;20(2):155-62.

PMID:
2890507
10.

Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.

Kukuk GM, Schaefer SG, Fimmers R, Hadizadeh DR, Ezziddin S, Spengler U, Schild HH, Willinek WA.

Eur Radiol. 2014 Oct;24(10):2482-90. doi: 10.1007/s00330-014-3291-x. Epub 2014 Jul 17.

PMID:
25030459
11.

Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese.

Zhang P, Wang CY, Li YX, Pan Y, Niu JQ, He SM.

World J Gastroenterol. 2015 Feb 28;21(8):2419-24. doi: 10.3748/wjg.v21.i8.2419.

12.

Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers.

Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H.

Int J Epidemiol. 1998 Jun;27(3):438-43.

PMID:
9698132
13.

Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity.

Anttila P, Järvi K, Latvala J, Romppanen J, Punnonen K, Niemelä O.

Scand J Clin Lab Invest. 2005;65(2):141-51.

PMID:
16025837
14.

[Carbohydrate deficient transferrin, gammaglutamyl transferase and mean corpuscular volume in the evaluation of recent alcohol intake in excessive drinkers].

Glasinovic JC, Lobos X, Scrivanti M, Severín MC, Quiroga T, Moncada C.

Rev Med Chil. 2001 Apr;129(4):375-81. Spanish.

PMID:
11413989
16.

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B; WHO/ISBRA Study Group.

Alcohol Clin Exp Res. 2002 Mar;26(3):332-9.

PMID:
11923585
17.

Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.

Yamini D, Lee SH, Avanesyan A, Walter M, Runyon B.

Alcohol Alcohol. 2014 Jul-Aug;49(4):453-6. doi: 10.1093/alcalc/agu028. Epub 2014 May 30.

PMID:
24939964
18.

Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking.

Chen J, Conigrave KM, Macaskill P, Whitfield JB, Irwig L; World Health Organization and the International Society for Biomedical Research on Alcoholism Collaborative Group.

Alcohol Alcohol. 2003 Nov-Dec;38(6):574-82.

PMID:
14633645
19.

Alcohol-attributable healthcare attendances up to 10 years prior to diagnosis of alcoholic cirrhosis: a population based case-control study.

Otete HE, Orton E, Fleming KM, West J.

Liver Int. 2016 Apr;36(4):538-46. doi: 10.1111/liv.13002. Epub 2015 Dec 29.

PMID:
26560966

Supplemental Content

Support Center